Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 4:10 PM View:  | Esperion Therapeutics, Inc. (ESPR) | 19-Nov-24 | Sale | 197 | $2.16 | $426.51 | (< 1%) 162.55K to 162.35K | |
| 18-Sep-24 4:11 PM View: | Esperion Therapeutics, Inc. (ESPR) | 17-Sep-24 | Sale | 2,608 | $1.78 | $4,650.06 | (2%) 165.27K to 162.66K | |
| 20-Aug-24 4:03 PM View: | Esperion Therapeutics, Inc. (ESPR) | 19-Aug-24 | Sale | 211 | $1.95 | $410.61 | (< 1%) 165.48K to 165.27K | |
| 19-Jul-24 8:30 AM View: | Esperion Therapeutics, Inc. (ESPR) | 17-Jul-24 | Sale | 108 | $2.59 | $279.40 | (< 1%) 165.59K to 165.48K | |
| 20-Jun-24 4:16 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Jun-24 | Sale | 2,540 | $2.86 | $7,254.24 | (2%) 168.13K to 165.59K | |
| 20-May-24 4:14 PM View: | Esperion Therapeutics, Inc. (ESPR) | 17-May-24 | Sale | 192 | $2.48 | $476.74 | (< 1%) 168.32K to 168.13K | |
| 15-Mar-24 4:35 PM View: | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-24 | Grant | 100,000 | -- | -- | 146% 68.32K to 168.32K | |
| 21-Sep-23 5:06 PM View: | Esperion Therapeutics, Inc. (ESPR) | 20-Sep-23 | Sale | 742 | $1.25 | $923.79 | (1%) 69.06K to 68.32K | |
| 21-Aug-23 4:32 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Aug-23 | Sale | 243 | $1.41 | $343.60 | (< 1%) 69.3K to 69.06K | |
| 20-Jul-23 4:38 PM View: | Esperion Therapeutics, Inc. (ESPR) | 19-Jul-23 | Sale | 106 | $1.59 | $168.01 | (< 1%) 69.41K to 69.3K | |
| 22-Jun-23 4:45 PM View: | Esperion Therapeutics, Inc. (ESPR) | 21-Jun-23 | Sale | 603 | $1.48 | $894.25 | (< 1%) 70.01K to 69.41K | |
| 18-May-23 4:07 PM View: | Esperion Therapeutics, Inc. (ESPR) | 17-May-23 | Sale | 219 | $1.62 | $355.66 | (< 1%) 70.23K to 70.01K | |
| 20-Apr-23 4:12 PM View: | Esperion Therapeutics, Inc. (ESPR) | 19-Apr-23 | Sale | 115 | $1.28 | $146.97 | (< 1%) 70.35K to 70.23K | |
| 20-Mar-23 4:16 PM View: | Esperion Therapeutics, Inc. (ESPR) | 17-Mar-23 | Sale | 526 | $1.78 | $937.49 | (< 1%) 70.87K to 70.35K | |
| 15-Mar-23 9:22 AM View: | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-23 | Grant | 22,300 | -- | -- | 46% 48.57K to 70.87K | |
| 08-Mar-23 4:22 PM View: | Esperion Therapeutics, Inc. (ESPR) | 07-Mar-23 | Private Sale | 5,090 | $5.05 | $25,729.90 | (9%) 53.66K to 48.57K | |
| 19-Oct-22 4:11 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Oct-22 | Private Sale | 107 | $7.69 | $822.83 | (< 1%) 53.77K to 53.66K | |
| 20-Sep-22 4:09 PM View: | Esperion Therapeutics, Inc. (ESPR) | 19-Sep-22 | Private Sale | 255 | $6.92 | $1,764.85 | (< 1%) 54.02K to 53.77K | |
| 31-Aug-22 4:14 PM View: | Esperion Therapeutics, Inc. (ESPR) | 31-Aug-22 | Purchase | 1,000 | $7.46 | $7,460.00 | 2% 53.02K to 54.02K | |
| 18-Aug-22 4:10 PM View: | Esperion Therapeutics, Inc. (ESPR) | 17-Aug-22 | Private Sale | 199 | $6.82 | $1,356.19 | (< 1%) 53.22K to 53.02K | |
| 20-Jul-22 4:27 PM View: | Esperion Therapeutics, Inc. (ESPR) | 19-Jul-22 | Private Sale | 431 | $6.58 | $2,836.84 | (< 1%) 53.65K to 53.22K | |
| 21-Jun-22 4:06 PM View: | Esperion Therapeutics, Inc. (ESPR) | 17-Jun-22 | Private Sale | 256 | $4.90 | $1,254.40 | (< 1%) 53.91K to 53.65K | |
| 18-May-22 4:30 PM View: | Esperion Therapeutics, Inc. (ESPR) | 17-May-22 | Private Sale | 196 | $5.98 | $1,172.28 | (< 1%) 54.11K to 53.91K | |
| 16-Mar-22 5:11 PM View: | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-22 | Grant | 13,000 | -- | -- | 32% 41.11K to 54.11K |